Publications
Detailed Information
The burden of symptomatic patients with chronic spontaneous urticaria: a real-world study in Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ye, Young-Min | - |
dc.contributor.author | Koh, Young-Il | - |
dc.contributor.author | Choi, Jeong-Hee | - |
dc.contributor.author | Kim, Mi-Ae | - |
dc.contributor.author | Park, Jung-Won | - |
dc.contributor.author | Kim, Tae-Bum | - |
dc.contributor.author | Nam, Young-Hee | - |
dc.contributor.author | Chang, Yoon-Seok | - |
dc.contributor.author | Park, Hae-Sim | - |
dc.date.accessioned | 2022-10-17T04:17:13Z | - |
dc.date.available | 2022-10-17T04:17:13Z | - |
dc.date.created | 2022-10-13 | - |
dc.date.issued | 2022-09 | - |
dc.identifier.citation | The Korean Journal of Internal Medicine, Vol.37 No.5, pp.1050-1060 | - |
dc.identifier.issn | 1226-3303 | - |
dc.identifier.uri | https://hdl.handle.net/10371/186180 | - |
dc.description.abstract | © 2022 The Korean Association of Internal Medicine.Background/Aims: Chronic spontaneous urticaria (CSU) poses a considerable burden both on the quality of life (QoL) of individual patients and on healthcare systems. Real-world data evaluating the disease burden of CSU are limited in this country. This study evaluated the disease burden and healthcare resource utilization (HRU) among symptomatic CSU patients. Methods: This multicenter, noninterventional, retrospective, and cross-sectional study assessed CSU patients symptomatic for more than 6 months despite step-wise H1-antihistamine medications. Primary outcomes included Urticaria Activity Score over 7 days (UAS7) and Chronic Urticaria QoL scale (CU-QoL). Secondary outcomes included EuroQol 5-Dimension 5-Level (EQ-5D-5L), Dermatology Life Quality Index (DLQI), association of disease activity with QoL, medications used for the past 6 months, and HRU. Results: Five hundred patients with CSU were enrolled. Mean disease duration was 3.7 years. Based on UAS7, 22.2% of patients were in well-controlled status and 31.2%, 28.4%, and 18.2% of them had mild, moderate, and severe disease, respectively. Mean CU-QoL and DLQI scores were 57.5 ± 29.7 and 10.2 ± 7.6, respectively, while the EQ-5D-5L utility score was 0.8 ± 0.2. H1-antihistamines were prescribed to 95% of patients, while omalizumab was prescribed to 33% of patients. Most patients (98%) had outpatient visits in the past 6 months. Negative correlations were noted between UAS7 and CU-QoL, EQ-5D-5L, EQ-5D-5L visual analog scale scores, but a positive correlation was noted with DLQI score (p < 0.001 for all). The number of outpatient department visits increased with disease activity (p = 0.001). Conclusions: CSU affects QoL, leading to increased HRU, particularly in patients with severe disease. | - |
dc.language | 영어 | - |
dc.publisher | 대한내과학회 | - |
dc.title | The burden of symptomatic patients with chronic spontaneous urticaria: a real-world study in Korea | - |
dc.type | Article | - |
dc.identifier.doi | 10.3904/kjim.2022.078 | - |
dc.citation.journaltitle | The Korean Journal of Internal Medicine | - |
dc.identifier.scopusid | 2-s2.0-85137311993 | - |
dc.citation.endpage | 1060 | - |
dc.citation.number | 5 | - |
dc.citation.startpage | 1050 | - |
dc.citation.volume | 37 | - |
dc.identifier.kciid | ART002868613 | - |
dc.description.isOpenAccess | N | - |
dc.contributor.affiliatedAuthor | Chang, Yoon-Seok | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.